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A B S T R A C T
Energy metabolism and redox state are intrinsically linked. In order to mount an adequate immune response,
cells must have an adequate and rapidly available energy resource to migrate to the inﬂammatory site, to
generate reactive oxygen species using NADPH as a cofactor and to engulf bacteria or damaged tissue. The ﬁrst
responder cells of the innate immune response, neutrophils, are largely dependent on glycolysis. Neutrophils
are relatively short-lived, dying via apoptosis in the process of bacterial killing through production of
hypochlorous acid and release of extracellular NETs. Later on, the most prevalent recruited innate immune
cells are monocytes. Their role is to complete a damage limitation exercise initiated by neutrophils and then, as
re-programmed M2 macrophages, to resolve the inﬂammatory event. Almost twenty ﬁve years ago, it was noted
that macrophages lose their glycolytic capacity and become anti-inﬂammatory after treatment with corticoster-
oids. In support of this we now understand that, in contrast to early responders, M2 macrophages are
predominantly dependent on oxidative phosphorylation for energy.
During early inﬂammation, polarisation towards M1 macrophages is dependent on NOX2 activation which,
via protein tyrosine phosphatase oxidation and AKT activation, increases traﬃcking of glucose transporters to
the membrane and consequently increases glucose uptake for glycolysis. In parallel, mitochondrial eﬃciency is
likely to be compromised via nitrosylation of the electron transport chain.
Resolution of inﬂammation is triggered by encounter with apoptotic membranes exposing oxidised
phosphatidylserine that interact with the scavenger receptor, CD36. Downstream of CD36, activation of
AMPK and PPARγ elicits mitochondrial biogenesis, arginase expression and a switch towards oxidative
phosphorylation in the M2 macrophage. Proinﬂammatory cytokine production by M2 cells decreases, but anti-
inﬂammatory and wound healing growth factor production is maintained to support restoration of normal
function.
1. Introduction to metabolism and redox state
Metabolism is the term used to describe those pathways that
provide energy from a variety of sources. Carbohydrates and lipids
are the major sources for energy in health and at rest, but during
starvation and in times of energy crisis, protein degradation provides a
necessary energy supply. Even the simplest unicellular organisms
respond to energy supply and demand by switching between energy-
producing catabolic processes and energy-consuming anabolic path-
ways.
During catabolism, carbohydrates are metabolised through glyco-
lysis and the pentose phosphate pathway (PPP) in the cytosol to feed
the citric acid cycle in the mitochondria and produce reducing
equivalents e.g. NADH, NADPH. The reduced nucleotides are required
for anabolic and redox reactions that require electrons. Fatty acids are
converted to acyl CoA derivatives then shuttled into the mitochondria
to undergo beta oxidation and generate short carbon chain regulatory
intermediates such as succinate. Through oxidative phosphorylation,
the electron gradient that forms the proton-motive force required for
ATP production is generated (Fig. 1). An unintended consequence of
less tightly coupled mitochondria is the production of superoxide anion
from complex I and III. The greater the metabolic load, the greater the
probability of free radical release.
In addition to feeding oxidative phosphorylation by mitochondria
to generate ATP, the reducing equivalents that are produced, such as
NADPH, are essential cofactors for ROS-generating NADPH oxidase
enzymes and also for antioxidant enzymes e.g. glutathione reductase
that catalyse the reduction of oxidised to reduced glutathione and
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restore redox state [41]. Thus, there is an irrefutable relationship
between metabolism and cellular redox state in all cells. The inter-
relationship is of greater signiﬁcance in cells that are metabolically
active. Cells of the immune system may spend a signiﬁcant time in a
resting phase and those that reside in tissue tend to rely on oxidative
phosphorylation in the absence of any challenge. However, the immune
system must be able to respond rapidly and eﬃciently to infection and
damage, and may revert to less eﬃcient but more responsive glycolysis
for the essential ATP that is needed for mounting an eﬀective immune
defence.
2. Energy demand by inﬂammatory cells
The main protagonists of the inﬂammatory response are neutro-
phils and monocytes that mature into macrophages. Neutrophils arrive
at sites of damage or infection within minutes by migrating direction-
ally along chemotactic gradients [34]. They are relatively short-lived,
dying via apoptosis in the process of bacterial killing through produc-
tion of hypochlorous acid and release of extracellular NETs [31].
Neutrophils shed microvesicles that carry important chemotactic
signals such as the leukotrienes that are derived from membrane
arachidonic acid [14]. Later, monocytes are recruited by chemotaxis to
inﬂammatory sites where the combination of bacterial products such as
LPS and the cytokine milieu combine to drive their diﬀerentiation into
macrophages [9]. Macrophages play an important role in phagocytic
clearance of infectious material and debris, providing a sustained anti-
infective army of resident cells (Fig. 2). In the majority of cells,
including macrophages, the largest source for ROS production is the
mitochondria. The reaction between superoxide and NO which leads to
the production of peroxynitrite, a powerful oxidant, proceeds at near
diﬀusion controlled rates (rate constant—7×109 M−1 s−1). Peroxynitrite
is important for bacterial killing by macrophages, targeting iron-
sulphur proteins.
Neutrophils and monocyte/macrophages are innate immune cells
and they work together with cells of the adaptive immune system, T
and B lymphocytes, which retain a memory of pathogen exposure and
are able to mount a rapid and speciﬁc response to subsequent infection.
At rest, the discrete classes of immune cells have distinctive metabolic
proﬁles (Fig. 3; adapted from [18]). The elegant studies by Kramer et al
demonstrated that resting lymphocytes are largely dependent on
oxidative phosphorylation and neutrophils are glycolytic.
In neutrophils, NOX2 produces ROS to kill bacteria and requires
NADPH as a cofactor. NADPH is supplied and its levels are sustained
when the PPP is active. The PPP is used when cells are over-supplied
with glucose to avoid excess production of the metabolite, lactate.
Glucose is shunted from glycolysis towards the PPP as lactate
concentrations rise ensuring that NADPH supply is suﬃcient for
NOX2 activity and that lactate levels are controlled.
The links between metabolism and the innate immune response
were ﬁrst drawn by Bustos and Sobrino; these authors identiﬁed that
stimulating glycolysis was suﬃcient to activate macrophages and that
corticosteroids, powerful anti-inﬂammatory agents, were inhibitors of
glycolysis [6]. Glycolysis provides a very rapid (although not very
eﬃcient) supply of energy which is ideally suited to the function of the
early recruited innate immune cells. During starvation, sarcopenia and
cachexia, proteins are degraded releasing amino acids to provide
energy. One of the pathways involved is glutaminolysis and this
metabolic pathway is common to all active and proliferating immune
cells [28].
Glutaminolysis is particularly important as an adjunct energy
source to glycolysis for lymphocytes that are undergoing proliferation
[38]. Tryptophan metabolism is also increasingly recognised as a
control node in immunity [26]. Metabolism must be dynamically
regulated during the immune response, integrating available nutrients
supplied from carbohydrate, lipids and proteins in order to provide
energy for innate immune cells to migrate, phagocytose and kill
pathogens.
3. Linking metabolism with monocyte function
One of the biggest challenges that has hindered improvements in
treating inﬂammatory disease has been our limited understanding of
how inﬂammation is resolved. It is now appreciated that innate
immune cells circulate and interchange between subsets with very
distinct properties. Over the last decade, understanding of monocyte
biology has been extended to deﬁne three subsets according to two
principle cell surface receptors [13]. The ﬁrst, CD14, is a co-receptor
for LPS from bacteria and the second, CD16, is a receptor for IgG that
Fig. 1. Major pathways for ATP generation in innate immune cells. Glucose and free fatty acids are the primary sources of energy for innate immune cells. Glucose is metabolised by
glycolysis (pink) when the cellular ATP requirement is high and nucleotide ﬂux is high e.g. for phagocytosis. The release of glucose from glycogen to meet this demand also fuels the
pentose phosphate pathway (PPP; blue). The PPP generates the reduced nucleotide NADPH that is essential for reducing enzyme (e.g. glutathione reductase) and NADPH oxidase
activity. Products of the pentose phosphate pathway can fuel ﬁve carbon sugar metabolism and feed back into the glycolytic pathway as pyruvate. After shuttling into the mitochondrion
(yellow), the citric acid cycle catalyses further carbon oxidation and generation of the reducing equivalents NADH and FADH2 which are substrates for oxidative phosphorylation. In
addition, succinyl and acetyl CoA can promote enzyme catalysed post-translational succinylation and acetylation of proteins within and outside of the mitochondrion. Tightly coupled
mitochondria harness the proton gradient generated across the membrane during nucleotide oxidation to generate ATP. When mitochondria are less well coupled, superoxide anion
radicals may be formed by single electron leakage to molecular oxygen. This is most likely to occur at complex 1. The generation of energy by innate immune cells is intimately related to
the cellular redox state.
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is in an immune complex; classical monocytes are deﬁned as (CD14+
+CD16-) Mon1, intermediate as (CD14++CD16+) Mon2 and non-
classical monocytes as (CD14+CD16++) Mon3 [42]. The classical
monocytes are most prevalent, possess a broad range of receptors
and can mediate tissue repair. Non-classical Mon3 monocytes are
considered to be highly motile, with patrolling and phagocytic activity.
Mon2 exhibit similar proinﬂammatory characteristics to Mon3 and
also have potent T-cell stimulatory function [39]. The ratio of these
subsets is altered during chronic and acute inﬂammation including
ageing, sepsis, liver ﬁbrosis, and rheumatoid arthritis with bias towards
an increase of Mon2 monocytes relative to other subsets [25]. Evidence
points towards the possibility for inter-conversion between monocyte
subsets. We have shown that the form of nutrient availability can
regulate subset plasticity [32] with palmitate promoting pro-inﬂam-
matory cytokine secretion and increasing cell surface CD11b expres-
sion. The proinﬂammatory eﬀect can be prevented by the monounsa-
turated fatty acid, oleate [11].
The transcriptional basis for determining macrophage polarization
into two subsets, M1 and M2, is better described than for monocytes
(Fig. 4) with HIF1α and NFkB driving the M1 phenotype and PGC1α
with STAT6 largely governing the M2 phenotype.
The bacterial product, lipopolysaccharide (LPS) and cytokines such
as IFNγ produced during the host response to viral infection are co-
stimulatory signals for monocyte diﬀerentiation to macrophages. This
in turn promotes the respiratory burst in macrophages through
traﬃcking of ﬂavocytochrome b558 from the cytoplasm to the plasma
membrane and NOX2 activation [8]. M1 macrophages are largely
glycolytic and this reﬂects their need for rapid energy production
during migration, ROS production by NOX2 and phagocytosis (Fig. 5).
The alternatively activated M2 state is triggered by the cytokines IL-
4 and IL-13 that are typically released by tissue mast cells that have
been activated by parasitic infection and damage signals. Following
receptor activation, STAT6 activates PGC1α, a transcriptional co-
activator that is a central inducer of mitochondrial biogenesis in cells,
increasing glucose and fatty acid metabolism via oxidative phosphor-
ylation [29] and illustrating the tight link between metabolism and
phenotype.
4. Redox regulation of the metabolic programme: the role of
the ROS
Fig. 6 illustrates some of the key redox sensitive steps that promote
glycolysis following inﬂammatory receptor engagement. Many inﬂam-
matory receptors in macrophages are coupled to NOX2, including
TLR4 that binds to bacterial LPS, the receptors that recognise pro-
inﬂammatory cytokines and immune complexes. Following receptor
activation, the respiratory burst increases fuelled by NADPH.
Superoxide anion radicals are the ﬁrst to be formed after NOX2
activation and are formed extracellularly or within the phagosome.
Fig. 2. Innate immune cell recruitment and ROS generation at inﬂammatory sites. (1) bacterial products such as the peptide formyl-methionine-leucine-phenylalanine (fMLP) and
lipopolysaccharide (LPS) form a chemical gradient (green) that is sensed initially by neutrophils circulating in the bloodstream. (2) The neutrophils are recruited down the
chemoattractant gradient where they recognize and engulf bacteria into a phagosome due to molecular patterns present on the bacterial surface. Within the phagosome, NOX2 produces
high concentrations of superoxide anion radicals (O2
-.) that dismutate to hydrogen peroxide H2O2. (3) In the presence of the neutrophilic enzyme, myeloperoxidase, hypochlorous acid
(HOCl) is fomed which triggers netosis, the release of extracellular traps of nucleic acid that immobilize extracellular bacteria for killing by ROS. The activated neutrophils also release
particles that form a chemotactic gradient for macrophage recruitment. (4) Migrating monocytes diﬀerentiate into macrophages in tissue. (5) Under the inﬂuence of LPS and the
cytokine interferon gamma (IFNγ), monocytes diﬀerentiate into M1 macrophages that produce O2
-., NO., H2O2 and peroxynitrite ONOO
-. to support the killing of bacteria and further
recruitment of other immune cells. (6) Later in a resolving inﬂammatory response, M2 macrophages are the most important cells, producing resolving lipid mediators, promoting
remodeling and repair of damaged tissue through secretion of growth factors such as TGFβ.
Fig. 3. The metabolic requirements of innate immune cells. Neutrophils are more
dependent on glycolysis to provide rapid bursts of energy that are necessary for ROS
production. Monocytes can use mitochondrial oxidative phosphorylation and glycolysis
to meet the energetic demands which vary according to whether the immune response is
in an inﬂammatory or resolution phase. Lymphocytes such as T cells are largely reliant
on oxidative phosphorylation however, can invoke amino acid metabolism to support this
at times of high energy demand (Adapted from Kramer et al., 2013).
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Superoxide anion radicals can dismutate rapidly to the lipophilic
hydrogen peroxide and diﬀuse into the cytoplasm to perform an
important second messenger function. Hydrogen peroxide is on the
one hand a powerful inhibitor of AMPK and on the other, through the
inhibition of protein tyrosine phosphatases (PTPs) is a powerful
activator of kinase signalling. One PTP, PTEN, is an inhibitor of
AKT/PKB activation and hence AKT signalling is increased during
oxidative stress when PTEN is inactivated. Downstream the redox
sensitive AKT promotes glucose uptake via GLUT4 traﬃcking to the
membrane to meet the energy demand of glycolysis [16] by classic M1
macrophage polarization.
The MAPK cascade is also activated after PTP inhibition, leading to
activation of IKK, degradation of IkB and NFkB activation. NFkB
promotes the transcription of many pro-inﬂammatory genes including
iNOS. In the presence of arginine, nitric oxide is formed and can diﬀuse
throughout the cytoplasm and into mitochondria where it has the
potential to form peroxynitrite with the superoxide anion. Our previous
work has shown that monocytes become proinﬂammatory in the
presence of the saturated fatty acid, palmitate, and this associates with
an increase in mitochondrial ROS production [12]. Peroxynitrite can
nitrosylate iron sulphur proteins in the electron transport chain and
inhibit electron transfer [21]. In this way, oxidative phosphorylation is
inhibited. The sum of these events is that the M1 macrophage will be
Fig. 4. ROS and metabolism in monocyte and macrophage subsets. Three monocyte subsets have been deﬁned in humans with diﬀerent functional properties. There is some evidence,
from animal models, for interchange between these subsets during pathology. According to diﬀerentiation cues, monocytes can polarize into one of two distinctive macrophage
phenotypes. Monocytes will polarize to pro-inﬂammatory M1 macrophages in the presence of LPS and IFNγ to produce O2
-., NO., H2O2. In the presence of IL-4 and IL-13, monocytes
diﬀerentiate to pro-resolving M2 macrophages with increased expression of anti-inﬂammatory cytokines and lipids.
Fig. 5. Macrophage metabolism. M1 macrophages produce the majority of their energy
requirements for bacterial killing by glycolysis whereas pro-resolving M2 macrophages
are mainly reliant on oxidative phosphorylation.
Fig. 6. ROS production is required for the switch to oxidative phosphorylation in M1 macrophages. Activation of inﬂammatory receptors (such as the toll-like receptor TLR4 by LPS) on
macrophages increases the localization of Phox to the membrane, the activation of NOX2 and the production of O2
-.. O2
-. can dismutate to H2O2 that is freely permeable through the
membrane. Intracellular H2O2 is a potent inhibitor of protein tyrosine phosphatases (PTP), that result in activation of AKT and MAPK signalling. AKT activation promotes the traﬃcking
of GLUT4 to the membrane and facilitates glucose uptake for glycolysis. MAPK activation triggers phosphorylation of IκK, degradation of IκB and the release of active NFκB.
Downstream of NFκB, an increase in expression of proinﬂammatory genes is observed, including inducible nitric oxide synthase (iNOS). In the presence of arginine, iNOS catalyses the
formation of NO. and, probably via peroxynitrite, promotes the nitrosylation of iron-sulphur (Fe-S) cluster proteins in the electron transport chain. Together glycolysis is promoted and
oxidative phosphorylation is inhibited via ROS.
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pro-inﬂammatory and glycolytic.
FOXO activity is also increased by MAPK signalling. FOXO
cooperates together with HIF1α to target the upregulation of inﬂam-
matory genes, glycolytic enzymes and the glucose transporter GLUT1.
In an iterative loop, LPS increases succinate concentrations derived
from glutamine-dependent anaplerosis to stabilise hypoxia-inducible
factor-1α through succinylation [37].
5. Redox regulation of the metabolic programme: the role of
HIF1α
Downstream from the activation of AKT/PKB by hydrogen peroxide
is the mammalian target of rapamycin (mTOR), a key feature of the
nutrient-sensing signalling network that controls cellular metabolism
[17]; Fig. 7. During energy depletion, TORC1 kinase activity is
inhibited but during nutrient-rich conditions, TORC1 is activated and
promotes anabolic cell growth. Conversely, TORC2 is sensitive to
glutamine catabolism and as the energy supply dwindles, promotes
generation of glutamine catabolites in order to restore metabolic
homeostasis [24].
mTOR is ubiquitous, has kinase activity and catalyses the phos-
phorylation and activation of the transcription factors that control
mitochondrial biogenesis and lipid metabolism [10]. This enables
maintenance of the nutrient supply necessary for mRNA translation
to begin. mTORC1 activates the anabolic protein synthesis pathway
which is required for cells to grow, proliferate and in the case of innate
immune cells, to produce inﬂammatory cytokines. Activation of
glycolysis, the PPP and de novo lipid biosynthesis occur in response
to TORC1 activation and are mediated via expression of HIF1α and
sterol regulatory element-binding proteins [10].
HIF1α is stabilised indirectly by nitrosylation following the sub-
sequent increase in peroxynitrite from increased iNOS expression
(NFkB-mediated iNOS expression); (Fig. 7). Stabilisation of HIF-1α
is achieved through S-nitrosation at Cys533 within the oxygen-depen-
dent degradation domain [22]. The chaperone, VHL, is unable to bind
to the oxidised PHD domain and VHL becomes ubiquitinated and
degraded. Correspondingly, the half-life of HIF1α is extended and it
binds to the constitutively expressed HIF1β. The heterodimeric HIF1
then directs an increase in expression of genes that promote survival
under hypoxia.
Several genes that are upregulated by HIF1 form part of the
glycolytic pathway. Thus, the increased half-life and transcriptional
activity of HIF1 ensures that the obvious cellular energy demand can be
met e.g. for migration and cytokine secretion. Over time, it is
anticipated that peroxynitrite levels would decline because of lower
mitochondrial ROS production. HIF1α would then be less likely to be
nitrosylated, and therefore would be more likely to be degraded, and
glycolytic enzyme production would decline. Eventually, AMP concen-
trations will increase. AMP is an important metabolic regulatory
molecule that facilitates the switch to oxidative phosphorylation.
6. Resolution of inﬂammation
The importance of redox signalling as a control mechanism for
macrophage activation has been extensively reviewed by Brune et al.
[4]. Nrf2 activation proceeds throughout the respiratory burst, hence
thiol redox state is rapidly restored by increased expression of the
redox couples Trx1, TrxR and GSH in the absence of further NOX
activation [23]. Trx1 with TrxR has also been suggested to have an
important role in the removal of nitrosothiols [3]. Trx1 reduction of
Cys in HIF1α and Fe-S clusters would be expected to increase the
eﬃciency of oxidative phosphorylation and inhibit glycolytic gene
expression due to HIF1 degradation.
As the inﬂammatory response progresses, ATP is consumed result-
ing in the build-up of metabolites lactate, NAD+ and AMP. These
metabolites send a nutrient-deﬁcit signal to switch the metabolic
phenotype of the macrophage and in turn its activity towards M2 via
AMPK, activation of NAMPT and SIRT activation (Fig. 8). It has been
reported that nitrosylation can be reversed by thiol donors which could
lead to restoration of the respiratory chain activity and oxidative
phosphorylation. In accordance with this hypothesis, denitrosylation
of HIF1α would also increase its rate of turnover and inhibit the
upregulation of glycolytic enzymes.
7. Redox regulation of the metabolic programme: the role of
the SIRT family
Nutrient- and energy-sensing signalling pathways are the nexus for
phenotypic programming. The metabolic response to nutrients is
tightly coordinated by sensing a combination of substrate and product
concentration and by changes in the activity or expression of rate-
limiting enzymes. Increasing concentrations of AMPK and NAD+ are
probably the most important regulatory products in metabolic switch-
ing. At the simplest level in glycolysis, phosphofructokinase (PFK) is
the rate limiting enzyme. PFK is allosterically inhibited by ATP (energy
excess) but conversely it is activated to drive glycolysis when AMP is in
excess (energy deﬁcit).
A further level of metabolic control in phenotypic programming is
mediated by the NAD+ dependent sirtuin (SIRT) family. In this case,
intracellular NAD+ concentration is a deacetylation-rate limiting factor
Fig. 7. The role for HIF1α in M1 macrophage metabolic phenotype. HIF1α is activated and stabilized under two oxidatively regulated pathways after inﬂammatory receptor engagement
by H2O2 that is generated from NOX2. One the one hand, activated AKT indirectly activates the mTOR complex and HIF1α is upregulated. Further activation of HIF1α is achieved by
nitrosylation of its oxygen dependent domain (ODD). Consequently, the VHL protein cannot bind to HIF1α and the protein is not directed towards degradation by the proteasome. With
increased stability comes increased transcriptional activity and HIF1α promotes increased expression of inﬂammatory (IL1α) and metabolic (hexokinase HK, phosphofructokinase PFK,
nicotinamide phosphoribosyltransferase NAMPT and glucose transporter 1 GLUT1) genes. The net consequence is that glycolysis activity is increased in M1 macrophages.
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and places NAD+ at the centre of redox state and metabolic regulation.
NAD+ is also an important metabolic intermediate; its concentration is
increased during low nutrient availability due to increased ﬂux of AMP
through the NAD+ salvage pathway and a corresponding low metabolic
ﬂux through the respiratory chain (Fig. 8).
The NAD+ salvage pathway comprises of nicotinamide phosphor-
ibosyltransferase (NAMPT) and nicotinamide mononucleotide adeny-
lyltransferase (NMNAT). NAMPT converts nicotinamide (NAM), the
product of NAD+ dependent deacetylation, to nicotinamide mononu-
cleotide (NMN) which is subsequently converted to NAD+ by NMNAT.
In contrast with this, during nutrient excess, increased glycolysis
leads to more pyruvate formation, increased intracellular acetyl-CoA,
the substrate for acetylation [15]. The dependence of SIRT1 activity on
NAD+ concentration directly links acetylation to inﬂammation, redox
state and the energy status of the cell (Fig. 9).
SIRT1 exerts further metabolic control over phenotype via control-
ling the extent of acetylation and therefore activity of PGC-1α [35] and
FOXO (1 and 3) [5]. SIRT1 is also a suppressor of inﬂammation by
inhibiting the NF-κB pathway. Nuclear p65 requires acetylation by
p300 to transcribe inﬂammatory genes such as TNFα. SIRT1 deacety-
lates lysine 310 and binds to the P65 subunit of the NF-κB complex to
prevent its phosphorylation and activation [40].
SIRT3-5 are found in the mitochondria. SIRT3 has de-acetylase
activity and regulates the activity of acetyl CoA synthetase. Nuclear
SIRT1 has been shown to activate RELB to diﬀerentially induce SIRT3
expression and increase mitochondrial biogenesis; this coordinates and
supports bioenergetic adaptation and highlights the central regulatory
node of SIRT1 [20]. SIRT4 has no detectable deacetylase activity,
however, it inhibits the activity of PPARα through nuclear SIRT1;
SIRT4 regulates NAD+ concentration and SIRT1 uses NAD+ supplied
through retrograde signalling to the nucleus for the regulation of
metabolic gene expression [18]. SIRT5 has demalonylase and desucci-
nylase activity [27].
Increasing concentration of the co-factor NAD+ increases activity of
Fig. 8. Depletion of nitric oxide and increasing antioxidant gene expression supports polarisation to M2 macrophages. As macrophages encounter apoptotic cells that have exposed
oxidised phosphatidyl serine on the outer membrane leaﬂet, downstream increases in PPARγ and AMPK activity are induced. Downstream of AMPK activation, an increase in NAD+
promotes SIRT1 activation deacetylation of mitochondrial genes, increases their expression and so increases oxidative phosphorylation potential. In parallel, the increase in PPARγ
causes an increase in arginase expression. Arginase consumes the substrate for iNOS, arginine, hence NO production becomes limited. In concert, AMPK and PPARγ enhance the activity
of PGC1α with a resulting increase in mitochondrial SOD expression. The latter protects mitochondrial membrane components from risk of oxidative damage by O2
-. removal. Citric acid
enzyme expression is also increased such that the substrates for oxidative phosphorylation, reduced nucleotides, are increased in concentration and support ATP production.
Fig. 9. The role of NAD+ in the macrophage metabolic switch. Inﬂammatory stimuli increase HIF1α expression which, together with NAMPT, promotes the regeneration of NAD+ from
the nicotinamide salvage pathway. NAD+ is an essential rate limiting substrate for SIRT1 activity. In the presence of active SIRT1, inﬂammation and glycolytic metabolism is inhibited
but mitochondrial biogenesis and fatty acid oxidation are promoted.
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SIRT1 and 6. SIRT6 is reported to deacetylate and inactivate glycolytic
enzymes. On the other hand, SIRT1 catalyses the deacetylation and
activation of PGC1α and components of the electron transport chain,
favouring mitochondrial biogenesis and an eﬃcient electron transport
chain. In addition, deacetylation of the p65 component of NFkB will
inhibit its activity and reduce pro-inﬂammatory gene transcription
[37].
Our own studies on substrate availability, have shown that the
proﬁle of available fatty acids in the plasma can prime monocytes to
polarise to either M1 or M2 macrophages, with saturated fatty acids
favouring the M1 and monounsaturated fatty acids favouring M2 [32].
Interaction with the CD36 receptor would promote activation of the
PPAR family, downstream expression of arginase, removal of the
substrate for nitric oxide synthase and anti-inﬂammatory cytokine
secretion (Fig. 9). For cells that are more dependent on oxidative
phosphorylation, mitochondrial maintenance is important to minimise
ROS production. Eﬃcient energy production is sustained because
damaged mitochondria are removed by mitophagy [30].
8. Dysregulation of inﬂammation: metabolism and redox
state in ﬂux
The timing of metabolic switching towards the resolution phase is
critical – too soon and there may not be eﬀective removal of pathogen,
and if the switch is delayed, a persistent systemic inﬂammation may
ensue (Fig. 10).
The nature and concentration of the nutrients in the circulation and
supplied to inﬂammatory cells may have important inﬂuences on
inﬂammatory outcome; increased circulating polyunsaturated fatty
acid (PUFA) content may inﬂuence cellular function in several ways.
First, PUFA are much more prone to oxidation by ROS and the lipid
oxidation products that are formed can be inﬂammatory [2]. Second,
some of the PUFA that are incorporated into membrane phospholipid
bilayers aﬀect membrane ﬂuidity and can increase phagocytic activity
in macrophages [7]. Finally, PUFA are important substrates in the
production of inﬂammatory and chemotactic eicosanoids (from arachi-
donic acid) and anti-inﬂammatory resolvins (from omega 3 fatty acids).
Eicosanoids and resolvins are produced by innate immune and non-
immune cells such as epithelial cells and can promote the inﬂammation
and its resolution according to the PUFA supply available to the cell
[1]. In addition to the well-established anti-inﬂammatory activity of
omega 3 fatty acids which are the precursors of resolvins, a switch to an
anti-inﬂammatory phenotype could be achieved by increasing mono-
unsaturated fatty acid nutrient availability during chronic inﬂamma-
tion.
9. Conclusion
In combination with reactive oxygen species, intermediates in
metabolism (particularly the concentration of NAD+ and AMP) play
an important role in control of inﬂammatory outcomes. On the one
hand, NOX2 activation is an early and important event in driving a
cascade of metabolic changes that promote glycolysis and inﬂamma-
tion. As nutrient depletion ensues, the SIRT family are activated
providing an important link between metabolism, resolution of inﬂam-
mation by coordinating the response to nutrients, mitochondrial
biogenesis, fatty acid and glucose metabolism. There remain some
outstanding questions.
a) Why do a number of anti-inﬂammatory drugs require ROS produc-
tion to be eﬀective [33,34]? Such drugs would be likely to promote
inﬂammatory signalling via PTP inhibition.
b) What is the relative importance of the liver compared with adipose
tissue for providing the energy for an eﬀective immune response
during an infection? Can remodelling of adipose tissue be directed
towards the release of anti-inﬂammatory fatty acids to promote
resolution of inﬂammation?
c) How does the timing of nutrient availability govern the dynamic
polarisation of immune cells? Increasing supply of nutrients that
promote resolution will presumably only be useful after the acute
phase has eﬀectively resolved the pathogenic challenges.
As we gain further understanding of these topics, the opportunity to
develop appropriately timed treatments to support the resolution of
dynamic inﬂammatory pathways will become a closer reality.
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Fig. 10. Metabolic drivers for the resolution of inﬂammation to prevent chronic inﬂammation. During the acute inﬂammatory response (red line), innate immune cells are dependent
on glycolysis. The induction of a resolution phase (blue line) is necessary to prevent persistent inﬂammation and oxidative damage. The switch is driven by ROS-enhanced HIF1α
stability and the activation of SIRT1 by increasing concentrations of salvaged NAD+ which increases the rate of mitochondrial activity. If an inﬂammatory stimulus persists or resolution
is not implemented eﬀectively, possibly by a failure to induce suﬃcient ROS as observed in chronic granulomatous disease and rheumatoid arthritis, HIF1α is not stabilised and
oxidative phosphorylation continues to be inhibited. Chronic inﬂammation associates with increased mitochondrial superoxide, oxidative damage and innate immune senescence with a
failure to resolve the inﬂammatory event.
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